FDA MedWatch Safety Information
Dec. 3, 2009

Audience: Neurological and Obstetrical healthcare professionals

The FDA notified health care professionals and patients about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodium and related products (valproic acid and divalproex sodium) during pregnancy. Healthcare practitioners should inform women of childbearing potential about these risks, and consider alternative therapies, especially if using valproate to treat migraines or other conditions not usually considered life-threatening.

Read entire article:  http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm192788.htm

« Return to news items

News Feed

Related Posts

• New Study—Psychiatric Drugs Cause Birth Defects— pregnant women warned about smoking/alcohol but not psychiatric drugs (0)
• Medscape – Psychotropic Medications Linked to Serious Adverse Drug Reactions in Children (1)
• University of Copenhagen; Psychiatric Drugs Cause Birth Defects—responsibility must be taken to warn pregnant women (0)
• Study shows antidepressants cause major increase in miscarriages (68%) yet pregnant women still being targeted for usage (0)
• UK Drug Regulatory Agency issues warning about potential birth defects from Prozac (1)

Tags: bipolar, birth defects, divalproex sodium, Pregnancy, valproate sodium, valproic acid

This entry was posted on Thursday, December 3rd, 2009 at 4:48 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed.

You can leave a response, or trackback from your own site.